Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 19.00
-1.00 (-5.00%)
At close: Sep 2, 2026
Biogened Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.13 | 4.94 | 5.82 | 5.1 | 3.38 | 1.96 |
Depreciation & Amortization | 4.87 | 4.37 | 4.13 | 3.52 | 2.94 | 2.88 |
Loss (Gain) From Sale of Assets | -0.58 | -0.42 | - | - | - | 0 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.49 |
Other Operating Activities | 2.43 | 2.21 | 2.37 | 2.16 | 1.7 | 0.59 |
Change in Accounts Receivable | 11.52 | -2.59 | -1.57 | -0.42 | 4.07 | -2.1 |
Change in Inventory | -1.7 | 6.25 | -7.02 | 1.15 | -8.14 | 0.61 |
Change in Other Net Operating Assets | -6.81 | -2.29 | 0.26 | 3.36 | 2.06 | -0.31 |
Operating Cash Flow | 14.84 | 12.47 | 4 | 14.87 | 6.01 | 3.14 |
Operating Cash Flow Growth | 300.12% | 212.18% | -73.13% | 147.34% | 91.42% | -63.93% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -7.44 | -7.35 | -5.49 | -7.15 | -9.36 | -1.57 |
Sale of Property, Plant & Equipment | 0.58 | 0.42 | - | - | - | - |
Investment in Securities | - | - | - | - | - | 0.49 |
Investing Cash Flow | -6.86 | -6.93 | -5.49 | -7.15 | -9.36 | -1.08 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 3.87 | 7.7 | 2.34 | 5.56 | 5.84 |
Long-Term Debt Repaid | - | -6.98 | -5.07 | -6 | -5 | -5.82 |
Net Debt Issued (Repaid) | 0.72 | -3.11 | 2.63 | -3.66 | 0.56 | 0.02 |
Common Dividends Paid | -1.23 | -1.23 | -1.23 | -0.98 | -0.74 | -0.49 |
Other Financing Activities | 0.36 | -0.95 | -1.35 | 0.98 | 2.01 | 0.83 |
Financing Cash Flow | -0.15 | -5.29 | 0.05 | -3.66 | 1.84 | 0.36 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 7.84 | 0.25 | -1.44 | 4.06 | -1.51 | 2.42 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 7.4 | 5.13 | -1.49 | 7.72 | -3.35 | 1.57 |
Free Cash Flow Growth | 756.58% | - | - | - | - | -77.13% |
Free Cash Flow Margin | 6.72% | 4.53% | -1.35% | 8.08% | -4.21% | 2.41% |
Free Cash Flow Per Share | 3.01 | 2.09 | -0.61 | 3.14 | -1.36 | 0.64 |
Levered Free Cash Flow | 7.52 | 2.42 | -6.06 | 6.42 | -3.06 | 7.82 |
Unlevered Free Cash Flow | 8.74 | 3.8 | -4.58 | 7.77 | -2 | 8.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.94 | 2.21 | 2.37 | 2.16 | 1.7 | 0.59 |
Change in Working Capital | 3.01 | 1.37 | -8.32 | 4.1 | -2.01 | -1.8 |